๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
An evaluation of the long term safety of tanezumab when administered by sub...
Status
Terminated
Location
Triwest Research Associates
Start Date
2010-06-15
Trial ID
NCT01127893
This study will investigate the safety of three fixed dose levels of tanezu...
Status
Terminated
Location
Mobile Diagnostic Center
Start Date
2009-11-17
Trial ID
NCT00994890
Treatments Being Tested
Test the efficacy and safety of 3 doses in Osteoarthritis of the knee in pa...
Status
Completed
Location
Arizona Research Center, Inc.
Start Date
2008-09-15
Trial ID
NCT00733902
The purpose of this study is to compare the long-term joint safety and effi...
Status
Completed
Location
Central Alabama Research
Start Date
2015-07-21
Trial ID
NCT02528188
Treatments Being Tested
Safety extension study of Phase 3 Osteoarthritis trials with Tanezumab...
Status
Terminated
Location
Pinncale Research Group, LLC
Start Date
2009-02-06
Trial ID
NCT00809783
In a previous study in patients with interstitial cystitis/ painful bladder...
Status
Terminated
Location
Alabama Orthopaedic Clinic
Start Date
2010-01-22
Trial ID
NCT00999518
The primary purpose of this study is to evaluate the efficacy of a titratio...
Status
Completed
Location
Alabama Orthopaedic Surgeons
Start Date
2016-01-21
Trial ID
NCT02697773
Treatments Being Tested
Tanezumab is a monoclonal antibody that binds to and inhibits the actions o...
Status
Completed
Location
Nuhr Medical Center
Start Date
2016-03-02
Trial ID
NCT02709486
The purpose of this study is to test the efficacy and safety of 3 doses of ...
Status
Completed
Location
Horizon Research Group
Start Date
2008-11-17
Trial ID
NCT00744471
This is an efficacy and safety study of 3 doses (2.5 mg, 5 mg and 10mg) of ...
Status
Terminated
Location
Vaughn H. Mancha, Jr., MD, PC
Start Date
2010-03-30
Trial ID
NCT01089725